Eastman Chemical Company (EMN) is facing any uncertainty due to
tariff tensions. First-quarter financial results for 2025 have been announced; while
earnings surpassed estimates, sales missed the expected mark. The company's share price has seen a series of reductions by key investment firms, such as Piper Sandler, Barclays, and JP Morgan, primarily due to the ongoing concerns related to tariffs. Despite this, there are opinions suggesting that EMN could be undervalued, and may be a worthwhile investment at its 52-week lows. The company has had some success with its
specialty chemicals and seeks long-term growth in spite of the tariff uncertainty. The company's fourth-quarter earnings of 2024 also beat estimates, while sales lagged. There are also indications that Eastman's dedication to the
circular economy, as highlighted in a SWOT analysis, might drive the stock's outlook.
Eastman Chemical Company EMN News Analytics from Tue, 15 Oct 2024 07:00:00 GMT to Thu, 01 May 2025 20:15:00 GMT -
Rating -2
- Innovation 1
- Information 5
- Rumor -3
